Alflutinib - CAS 1869057-83-9

Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition.

EGFR, Cytochromes P450

Angiogenesis, JAK/STAT signaling, Metabolism, Tyrosine Kinase/Adaptors

1869057-83-9

0.9987

C28H31F3N8O2

568.59

CN1C=C(C=2C1=CC=CC2)C3=NC(NC4=C(OCC(F)(F)F)N=C(N(CCN(C)C)C)C(NC(C=C)=O)=C4)=NC=C3

-20°C

Ice Packs

Small Compound